ArticleHepatobiliary surgery and nutrition2024

Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study.

Jingzhong Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.